Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

Webinar – Expanding Proteomic Horizons with Single-Molecule Proteome and Proteoform Analysis

Key Takeaway: Nautilus is hosting a webinar to showcase its Proteome Analysis Platform, which focuses on single-molecule protein analysis. This technology aims to enhance proteomics through improved sensitivity and reproducibility, allowing for the identification of a vast majority of the human proteome. The webinar will detail recent advancements, including the quantification of complex proteoforms like tau, highlighting the platform's potential impact on biological research.
Price reaction · baseline $2.61 (2024-03-26 close) · hit after-hours · clean, no other NAUT news in the window
day 0 close
+6.1%
day 1 · peak
+12.6%
day 3
+3.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Innovative single-molecule protein analysis technology
  • Potential to identify over 95% of the human proteome
  • Demonstrates capability to quantify modified proteoforms
  • Impacts biological research and human health positively

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

Events
Jamie Rose Kuhar
March 26, 2024
Single-molecule protein analysis is key to enabling a wide range of advancements in proteomics including increased sensitivity, reproducibility, and scale. We are building the Nautilus Proteome Analysis Platform to deliver comprehensive coverage of the proteome, including resolution of proteoforms.
Toward this end, we have built novel biochemistry for single, intact protein molecule immobilization, instrumentation for highly sensitive iterative probing of those protein molecules with a diverse range of affinity-reagents, and machine learning for data interpretation. Simulations using multi-affinity probes that bind short (2-4 amino acid) epitopes show that the accumulated information from multiple rounds of detection enables identification of more than 95% of the human proteome with just 300 probes.
View our webinar for a walkthrough of our technology and a deep dive into the latest data we presented at US HUPO 2024. The data demonstrates protein quantification using Protein Identification by Short-epitope Mapping (PrISM) and showcases early platform performance that will pave the way to conquering the proteome. Additionally, we share data illustrating how the platform can quantify highly modified proteoforms such as tau using standard, commercially-available affinity reagents. Combined, these data demonstrate the incredible power of our single-molecule analysis platform and its potential to impact biological research and human health.
Share this Article
Stay up-to-date on all things Nautilus
World-class articles, delivered weekly
MORE ARTICLES
Proteomics could unlock how tau protein and Alzheimer’s are linked
Learn about the links between tau and Alzheimer's and find out how we're using the Nautilus platform to better understand their connections.
Read more
Join Nautilus at HUPO 2022 in Cancun Mexico
We're attending HUPO 2022 in Cancun Mexico, December 4th – 8th! In this post we describe all the ways you can interact with us at HUPO 2022.
Read more
Three takeaways from HUPO 2022 in Cancun Mexico
In this blog post we share our 3 key proteomics take aways from our incredible time at HUPO 2022 in Cancun Mexico.
Read more
Stay up-to-date on all things Nautilus

Subscribe to our Newsletter

Frequently Asked Questions

What is the focus of the Nautilus webinar?

The webinar focuses on the Nautilus Proteome Analysis Platform and single-molecule protein analysis.

How does the platform enhance proteomics?

It improves sensitivity, reproducibility, and scale, allowing for extensive proteome coverage.

What can the platform quantify?

It can quantify highly modified proteoforms, including tau, using commercially available affinity reagents.

What is the expected outcome of the technology?

The technology aims to identify over 95% of the human proteome with just 300 probes.

Last updated: Mar 26, 2024